Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression

BACKGROUND: There is a clear need to develop biomarkers for Parkinson disease (PD) diagnosis, differential diagnosis of parkinsonian disorders, and monitoring disease progression. We and others have demonstrated that a decrease in DJ-1 and/or α-synuclein in the cerebrospinal fluid (CSF) is a potenti...

詳細記述

保存先:
書誌詳細
主要な著者: Shi, Min, Bradner, Joshua, Hancock, Aneeka M., Chung, Kathryn A., Quinn, Joseph F., Peskind, Elaine R., Galasko, Douglas, Jankovic, Joseph, Zabetian, Cyrus P., Kim, Hojoong M., Leverenz, James B., Montine, Thomas J., Ginghina, Carmen, Kang, Un Jung, Cain, Kevin C., Wang, Yu, Aasly, Jan, Goldstein, David S., Zhang, Jing
フォーマット: Artigo
言語:Inglês
出版事項: 2011
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117674/
https://ncbi.nlm.nih.gov/pubmed/21400565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.22311
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料